Clinical applications of arterial spin labeling

NMR in Biomedicine

Volumn 26, Issue 8, 2013, Pages 892-900

  Watts, Jonathan M ^a   Whitlow, Christopher T ^a   Maldjian, Joseph A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Arterial spin labeling; Cerebral perfusion; Neuro oncology

Indexed keywords

ARTERIAL SPIN LABELING; BRAIN TUMORS; CEREBRAL BLOOD FLOW; CEREBRAL PERFUSION; CEREBROVASCULAR DISEASE; CLINICAL APPLICATION; NEURO-ONCOLOGY; OPTIMAL UTILIZATION;

MEDICINE; SPECTROSCOPY;

NEUROIMAGING;

CITALOPRAM;

ALZHEIMER DISEASE; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN DEATH; BRAIN ISCHEMIA; BRAIN PERFUSION; CEREBROVASCULAR DISEASE; CONVENTIONAL ANGIOGRAPHY; DEMENTIA; HUMAN; MAJOR DEPRESSION; MIGRAINE; MILD COGNITIVE IMPAIRMENT; MOYAMOYA DISEASE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA; SEIZURE; SPIN LABELING;

ARTERIAL SPIN LABELING; CEREBRAL PERFUSION; NEURO-ONCOLOGY;

BODY WATER; BRAIN DEATH; BRAIN DISEASES; BRAIN NEOPLASMS; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; DEMENTIA; GLIOMA; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MAGNETIC RESONANCE IMAGING; MENTAL DISORDERS; NEUROIMAGING; NITROUS OXIDE; SEIZURES; SPIN LABELS; SUBTRACTION TECHNIQUE;

EID: 84880954891     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2904     Document Type: Article

References (64)

1. Kety SS, Schmidt CF. The nitrous oxide method for the quantitative determination of cerebral blood flow in man; theory, procedure and normal values. J. Clin. Invest. 1948; 27(4): 476-483.
2. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke, 1981; 12(6): 723-725.
3. Latchaw RE, Yonas H, Hunter GJ, Yuh WT, Ueda T, Sorensen AG, Sunshine JL, Biller J, Wechsler L, Higashida R, Hademenos G, Council on Cardiovascular Radiology of the American Heart Association. Guidelines and recommendations for perfusion imaging in cerebral ischemia: a scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke, 2003; 34(4): 1084-1104.
4. Pollock JM, Tan H, Kraft RA, Whitlow CT, Burdette JH, Maldjian JA. Arterial spin-labeled MR perfusion imaging: clinical applications. Magn. Reson. Imaging Clin. N. Am. 2009; 17(2): 315-338.
5. Fiehler J, von Bezold M, Kucinski T, Knab R, Eckert B, Wittkugel O, Zeumer H, Rother J. Cerebral blood flow predicts lesion growth in acute stroke patients. Stroke, 2002; 33(10): 2421-2425.
6. Schlaug G, Benfield A, Baird AE, Siewert B, Lovblad KO, Parker RA, Edelman RR, Warach S. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology, 1999; 53(7): 1528-1537.
7. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Woods RP, Alger JR. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology, 2001; 57(11): 2015-2021.
8. Meng Y, Wang P, Kim SG. Simultaneous measurement of cerebral blood flow and transit time with turbo dynamic arterial spin labeling (Turbo-DASL): application to functional studies. Magn. Reson. Med. 2011; 68(3): 762-771.
9. Yan L, Li C, Kilroy E, Wehrli FW, Wang DJ. Quantification of arterial cerebral blood volume using multiphase-balanced SSFP-based ASL. Magn. Reson. Med. 2011; 68(1): 130-139.
10. Jones CE, Wolf RL, Detre JA, Das B, Saha PK, Wang J, Zhang Y, Song HK, Wright AC, Mohler EM 3rd, Fairman RM, Zager EL, Velazquez OC, Golden MA, Carpenter JP, Wehrli FW. Structural MRI of carotid artery atherosclerotic lesion burden and characterization of hemispheric cerebral blood flow before and after carotid endarterectomy. NMR Biomed. 2006; 19(2): 198-208.
11. Roberts DA, Detre JA, Bolinger L, Insko EK, Leigh JS Jr. Quantitative magnetic resonance imaging of human brain perfusion at 1.5T using steady-state inversion of arterial water. Proc. Natl. Acad. Sci. USA, 1994; 91(1): 33-37.
12. Kitajima M, Hirai T, Shigematsu Y, Fukuoka H, Sasao A, Okuda T, Morioka M, Kai Y, Yamashita Y. Assessment of cerebral perfusion from bypass arteries using magnetic resonance regional perfusion imaging in patients with moyamoya disease. Jpn. J. Radiol. 2010; 28(10): 746-753.
13. Zaharchuk G, Do HM, Marks MP, Rosenberg J, Moseley ME, Steinberg GK. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke, 2011; 42: 2485-2491.
14. Yun TJ, Sohn CH, Yoon BW, Jeon BS, Choi SH, Kim JH, Han MH, Chang KH. Brain death: evaluation of cerebral blood flow by use of arterial spin labeling. Circulation, 2011; 124: 2572-2573.
15. Ludemann L, Jedrzejewski G, Heidenreich J, Han ET, Bruhn H. Perfusion imaging of cerebral arteriovenous malformations: a study comparing quantitative continuous arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging at 3 T. Magn. Reson. Imaging, 2011; 29(9): 1157-1164.
16. Pollock JM, Whitlow CT, Simonds J, Stevens EA, Kraft RA, Burdette JH, Maldjian JA. Response of arteriovenous malformations to gamma knife therapy evaluated with pulsed arterial spin-labeling MRI perfusion. Am. J. Roentgenol. 2011; 196(1): 15-22.
17. Wolf RL, Wang J, Detre JA, Zager EL, Hurst RW. Arteriovenous shunt visualization in arteriovenous malformations with arterial spin-labeling MR imaging. Am. J. Neuroradiol. 2008; 29(4): 681-687.
18. Le TT, Fischbein NJ, Andre JB, Wijman C, Rosenberg J, Zaharchuk G. Identification of venous signal on arterial spin labeling improves diagnosis of dural arteriovenous fistulas and small arteriovenous malformations. Am. J. Neuroradiol. 2012; 33(1): 61-68.
19. Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA. Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. Am. J. Neuroradiol. 2008; 29(7): 1228-1234.
20. Biagi L, Abbruzzese A, Bianchi MC, Alsop DC, Del Guerra A, Tosetti M. Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. J. Magn. Reson. Imaging, 2007; 25(4): 696-702.
21. Whitlow C, Pollock J, Mussat-Whitlow B. Changes in global rates of cerebral perfusion associated with normal development as measured with MR arterial spin labeling. American Society of Neuroradiology 46th Annual Meeting, New Orleans, LA, USA, 2008.
22. Pollock JM, Deibler AR, Burdette JH, Kraft RA, Tan H, Evans AB, Maldjian JA. Migraine associated cerebral hyperperfusion with arterial spin-labeled MR imaging. Am. J. Neuroradiol. 2008; 29(8): 1494-1497.
23. Feske SK. Posterior reversible encephalopathy syndrome: a review. Semin. Neurol. 2011; 31(2): 202-215.
24. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2): 97-109.
25. Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC, Golfinos JG, Zagzag D, Johnson G. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology, 2008; 247(2): 490-498.
26. Hirai T, Kitajima M, Nakamura H, Okuda T, Sasao A, Shigematsu Y, Utsunomiya D, Oda S, Uetani H, Morioka M, Yamashita Y. Quantitative blood flow measurements in gliomas using arterial spin-labeling at 3T: intermodality agreement and inter- and intraobserver reproducibility study. Am. J. Neuroradiol. 2011; 32(11): 2073-2079.
27. Lehmann P, Monet P, de Marco G, Saliou G, Perrin M, Stoquart-Elsankari S, Bruniau A, Vallee JN. A comparative study of perfusion measurement in brain tumours at 3 Tesla MR: arterial spin labeling versus dynamic susceptibility contrast-enhanced MRI. Eur. Neurol. 2010; 64(1): 21-26.
28. Ludemann L, Warmuth C, Plotkin M, Forschler A, Gutberlet M, Wust P, Amthauer H. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. Eur. J. Radiol. 2009; 70(3): 465-474.
29. Warmuth C, Gunther M, Zimmer C. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology, 2003; 228(2): 523-532.
30. Shin JH, Lee HK, Kwun BD, Kim JS, Kang W, Choi CG, Suh DC. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Am. J. Roentgenol. 2002; 179(3): 783-789.
31. Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin. Radiol. 2005; 60(4): 493-502.
32. Noguchi T, Yoshiura T, Hiwatashi A, Togao O, Yamashita K, Nagao E, Shono T, Mizoguchi M, Nagata S, Sasaki T, Suzuki SO, Iwaki T, Kobayashi K, Mihara F, Honda H. Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. Am. J. Neuroradiol. 2008; 29(4): 688-693.
33. Varlet P, Jouvet A, Miquel C, Saint-Pierre G, Beuvon F, Daumas-Duport C. Criteria of diagnosis and grading of oligodendrogliomas or oligo-astrocytomas according to the WHO and Sainte-Anne classifications. Neurochirurgie, 2005; 51(3-4 Pt 2): 239-246.
34. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology, 2005; 234: 851-859.
35. Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 2010; 6: 202-211, e207.
36. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol. Aging, 2011; 32: 1207-1218.
37. Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES, Newberg AB, Julin P, Arnold SE, Greenberg JH, Detre JA. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology, 2011; 77: 1977-1985.
38. Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, Alavi A, Kimberg DY, Wolk DA, Julin P, Newberg AB, Arnold SE, Detre JA. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement. 2011; 8(1): 51-59.
39. Alsop DC, Dai W, Grossman M, Detre JA. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J. Alzheimers Dis. 2010; 20: 871-880.
40. Alexopoulos P, Sorg C, Forschler A, Grimmer T, Skokou M, Wohlschlager A, Perneczky R, Zimmer C, Kurz A, Preibisch C. Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI. Eur. Arch. Psychiatry Clin. Neurosci. 2011; 262(1): 69-77.
41. Chao LL, Buckley ST, Kornak J, Schuff N, Madison C, Yaffe K, Miller BL, Kramer JH, Weiner MW. ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis. Assoc. Disord. 2010; 24: 19-27.
42. Du AT, Jahng GH, Hayasaka S, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin KP, Miller BL, Weiner MW, Schuff N. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology, 2006; 67: 1215-1220.
43. Shimizu S, Zhang Y, Laxamana J, Miller BL, Kramer JH, Weiner MW, Schuff N. Concordance and discordance between brain perfusion and atrophy in frontotemporal dementia. Brain Imaging Behav. 2010; 4(1): 46-54.
44. Zhang Y, Schuff N, Ching C, Tosun D, Zhan W, Nezamzadeh M, Rosen HJ, Kramer JH, Gorno-Tempini ML, Miller BL, Weiner MW. Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia. Int. J. Alzheimers Dis. 2011; 2011: 546871.
45. Hu WT, Wang Z, Lee VM, Trojanowski JQ, Detre JA, Grossman M. Distinct cerebral perfusion patterns in FTLD and AD. Neurology, 2010: 75: 881-888.
46. Firbank MJ, He J, Blamire AM, Singh B, Danson P, Kalaria RN, O'Brien JT. Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology, 2011; 76: 1478-1484.
47. Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, Miller BL, Kramer JH, Jagust WJ, Chui HC, Weiner MW. Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement. 2009; 5: 454-462.
48. Kamagata K, Motoi Y, Hori M, Suzuki M, Nakanishi A, Shimoji K, Kyougoku S, Kuwatsuru R, Sasai K, Abe O, Mizuno Y, Aoki S, Hattori N. Posterior hypoperfusion in Parkinson's disease with and without dementia measured with arterial spin labeling MRI. J. Magn. Reson. Imaging, 2011; 33(4): 803-807.
49. Melzer TR, Watts R, MacAskill MR, Pearson JF, Rueger S, Pitcher TL, Livingston L, Graham C, Keenan R, Shankaranarayanan A, Alsop DC, Dalrymple-Alford JC, Anderson TJ. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain, 2011; 134: 845-855.
50. Wolf RC, Gron G, Sambataro F, Vasic N, Wolf ND, Thomann PA, Saft C, Landwehrmeyer GB, Orth M. Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease. J. Cereb. Blood Flow Metab. 2011; 31: 1908-1918.
51. Dashjamts T, Yoshiura T, Hiwatashi A, Yamashita K, Abe K, Ohyagi Y, Kira J, Honda H. Asymmetrical cerebral perfusion demonstrated by noninvasive arterial spin-labeling perfusion imaging in a patient with corticobasal degeneration. Jpn. J. Radiol. 2010; 28(1): 75-78.
52. Theberge J. Perfusion magnetic resonance imaging in psychiatry. Top. Magn. Reson. Imaging, 2008; 19: 111-130.
53. Duhameau B, Ferre JC, Jannin P, Gauvrit JY, Verin M, Millet B, Drapier D. Chronic and treatment-resistant depression: a study using arterial spin labeling perfusion MRI at 3 Tesla. Psychiatry Res. 2010; 182: 111-116.
54. Jarnum H, Eskildsen SF, Steffensen EG, Lundbye-Christensen S, Simonsen CW, Thomsen IS, Frund ET, Theberge J, Larsson EM. Longitudinal MRI study of cortical thickness, perfusion, and metabolite levels in major depressive disorder. Acta Psychiatr. Scand. 2011; 124(6): 435-446.
55. Lui S, Parkes LM, Huang X, Zou K, Chan RC, Yang H, Zou L, Li D, Tang H, Zhang T, Li X, Wei Y, Chen L, Sun X, Kemp GJ, Gong QY. Depressive disorders: focally altered cerebral perfusion measured with arterial spin-labeling MR imaging. Radiology, 2009; 251: 476-484.
56. Clark CP, Frank LR, Brown GG. Sleep deprivation, EEG, and functional MRI in depression: preliminary results. Neuropsychopharmacology, 2001; 25: S79-S84.
57. Clark CP, Brown GG, Archibald SL, Fennema-Notestine C, Braun DR, Thomas LS, Sutherland AN, Gillin JC. Does amygdalar perfusion correlate with antidepressant response to partial sleep deprivation in major depression? Psychiatry Res. 2006; 146: 43-51.
58. Clark CP, Brown GG, Frank L, Thomas L, Sutherland AN, Gillin JC. Improved anatomic delineation of the antidepressant response to partial sleep deprivation in medial frontal cortex using perfusion-weighted functional MRI. Psychiatry Res. 2006; 146: 213-222.
59. Benedetti F, Smeraldi E. Neuroimaging and genetics of antidepressant response to sleep deprivation: implications for drug development. Curr. Pharm. Des. 2009; 15(22): 2637-2649.
60. Chen Y, Wan HI, O'Reardon JP, Wang DJ, Wang Z, Korczykowski M, Detre JA. Quantification of cerebral blood flow as biomarker of drug effect: arterial spin labeling phMRI after a single dose of oral citalopram. Clin. Pharmacol. Ther. 2011; 89: 251-258.
61. Drevets WC. Neuroimaging studies of mood disorders. Biol. Psychiatry, 2000; 48(8): 813-829.
62. Pinkham A, Loughead J, Ruparel K, Wu WC, Overton E, Gur R. Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI. Psychiatry Res. 2011; 194(1): 64-72.
63. Scheef L, Manka C, Daamen M, Kuhn KU, Maier W, Schild HH, Jessen F. Resting-state perfusion in nonmedicated schizophrenic patients: a continuous arterial spin-labeling 3.0-T MR study. Radiology, 2010; 256(1): 253-260.
64. Walther S, Federspiel A, Horn H, Razavi N, Wiest R, Dierks T, Strik W, Muller TJ. Resting state cerebral blood flow and objective motor activity reveal basal ganglia dysfunction in schizophrenia. Psychiatry Res. 2010; 192: 117-124.